# Generare Raises $23.2M to Discover Unknown Molecules and Advance New Drugs

> **Platform:** [SPIDITS AI](https://spidits.com/) — Real-Time AI News & Market Intelligence  
> **Published:** 2026-04-02T06:00:37.000Z  
> **Category:** FUNDING  
> **Impact Score:** 140/100  
> **Primary Source:** [SiliconANGLE](https://siliconangle.com/2026/04/02/generare-raises-23-2m-discover-unknown-molecules-advance-new-drugs)  
> **Canonical Citation:** [https://spidits.com/timeline/generare-raises-23-2m-to-discover-unknown-molecules-and-advance-new-drugs](https://spidits.com/timeline/generare-raises-23-2m-to-discover-unknown-molecules-and-advance-new-drugs)

## Executive Summary
Generare Bioscience SAS, a Paris-based biotechnology company generating never-before-seen molecular data for drug development using artificial intelligence, announced today it has raised €20 million, about $23.3 million, in an early-stage funding round co-led by Alven and Daphni.

## Referenced Coverage & Sources
- **[SiliconANGLE](https://siliconangle.com/2026/04/02/generare-raises-23-2m-discover-unknown-molecules-advance-new-drugs)**: Generare raises $23.2M to discover unknown molecules and advance new drugs — _Generare Bioscience SAS, a Paris-based biotechnology company generating never-before-seen molecular data for drug development using artificial intelligence, announced today it has raised €20 million, about $23.3 million, in an early-stage funding round co-led by Alven and Daphni. All existing..._

---
*Synthesized by SPIDITS AI Market Intelligence Desk. Track live AI news, model releases, and funding: [https://spidits.com](https://spidits.com)*